For me an investment in RVX is all about Apabetalone and the BETonMACE trial....I see it as being a multi billion dollar compound/drug/whatever, and that's multiple billions in USD if the trial succeeds.  Adding 5 or 6 or even 10 or 20 million shares, no matter what they're priced at, that doesn't change my opinion about the potential value here.  

Assign RVX a MC of $2 billion in USD and I don't care whether the number of shares is 100 or 200 or even 300 million, obviously the fewer the better but at $2 billion USD anything under $3 is still an incredible bargain.  

Just to put my view in perspective, if RVX had 300 million shares OS fully diluted and a MC of USD $2 billion, my math puts the PPS at about $6.66 USD....or close to $9 CDN.  Obviously the recent dilution doesn't come anywhere close to putting the share count at 300 million....and I doubt any subsequent dilution would get it that high, at least not in the near to medium term.  

Tuesday evening the short number should be out....and all the guessing about whether shorts covered or added, its all still guessing at this point.  I will wait to see the number.  I do hope it was simply a matter of capitulation that caused the share price to crater, but I'm not going to worry too much either if Shorts piled on by borrowing and dumping a large number of shares back into the market to drive the price down.